A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resection

被引:0
|
作者
Shenglan Huang
Dan Li
LingLing Zhuang
Liying Sun
Jianbing Wu
机构
[1] The Second Affiliated Hospital of Nanchang University,Department of Oncology
[2] The Second Affiliated Hospital of Nanchang University,Department of Gynaecology
关键词
Hepatocellular carcinoma; HCC; Sorafenib; Resection; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
下载
收藏
相关论文
共 50 条
  • [31] Sorafenib in combination with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis
    Hu, M-D.
    Jia, L-H.
    Liu, H-B.
    Zhang, K-H.
    Guo, G-H.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (01) : 64 - 74
  • [32] A network meta-analysis evaluating the efficacy and safety of adjuvant therapy after nephrectomy in renal cell carcinoma
    Guo, Lingyu
    An, Tian
    Huang, Zhixin
    Chong, Tie
    BMC UROLOGY, 2024, 24 (01)
  • [33] Efficacy and safety of adjuvant therapy after curative surgery for ampullary carcinoma: A systematic review and meta-analysis
    Vo, Nguyen-Phong
    Nguyen, Hung Song
    Loh, El-Wui
    Tam, Ka-Wai
    SURGERY, 2021, 170 (04) : 1205 - 1214
  • [34] A network meta-analysis evaluating the efficacy and safety of adjuvant therapy after nephrectomy in renal cell carcinoma
    Lingyu Guo
    Tian An
    Zhixin Huang
    Tie Chong
    BMC Urology, 24
  • [35] A meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma
    Wang, Jun
    He, Xiao Dong
    Yao, Nan
    Liang, Wen Jia
    Zhang, You Cheng
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 27 (06) : 351 - 363
  • [36] Treatment Efficacy Differences of Sorafenib for Advanced Hepatocellular Carcinoma: A Meta-Analysis of Randomized Clinical Trials
    Shao, Yu-Yun
    Shau, Wen-Yi
    Chan, Soa-Yu
    Lu, Li-Chun
    Hsu, Chih-Hung
    Cheng, Ann-Lii
    ONCOLOGY, 2015, 88 (06) : 345 - 352
  • [37] Efficacy and Safety of Sorafenib or Lenvatinib for Advanced Hepatocellular Carcinoma after Failure of First-Line Atezolizumab Plus Bevacizumab: A Systematic Review and Meta-Analysis
    Peng, Tzu-Rong
    Weng, Yi-Fang
    Wu, Ta-Wei
    Wu, Chao-Chuan
    Chou, Yi-Chun
    Hsu, Ching-Sheng
    CANCERS, 2024, 16 (16)
  • [38] Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy
    Kim, Pyeong Hwa
    Choi, Sang Hyun
    Kim, Jin Hyoung
    Park, Seong Ho
    KOREAN JOURNAL OF RADIOLOGY, 2019, 20 (03) : 385 - 398
  • [39] The clinical efficacy and safety of kanglaite adjuvant therapy in the treatment of advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis
    Liu, Jingjing
    Liu, Xueni
    Ma, Jing
    Li, Ke
    Xu, Chao
    BIOSCIENCE REPORTS, 2019, 39
  • [40] Efficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
    Gupta, Nandini
    Verma, Neelkant
    Patel, Bhoomika
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (04) : 1485 - 1497